16.1 All relevant personnel including representatives and members of staff (including persons retained by way of contract with third parties) concerned in any way with the preparation or approval of promotional material or of information to be provided to members of the UK health professions and to appropriate administrative staff or of information to be provided to the public and recognised patient organisations must be fully conversant with the requirements of the Code and the relevant laws and regulations.
16.2 All personnel (including persons retained by way of contract with third parties) must be fully conversant with pharmacovigilance requirements relevant to their work and this must be documented.
16.3 Representatives must take an appropriate examination within their first year of employment as a representative and must pass it within two years of starting such employment.
To be acceptable, an examination must have been accredited to at least Level 3 by an external awarding body recognised by Ofqual.
An appropriate examination for medical representatives is one that requires a broad understanding of body systems, diseases and treatments, the development of new medicines and the structure and function of the NHS and of the pharmaceutical industry. Such an examination must be a Diploma (at least 37 credits or equivalent learning hours).
An appropriate examination for generic sales representatives is one that requires a broad understanding of body systems, the structure and function of the NHS and of the pharmaceutical industry. Such an examination must be a Certificate (at least 13 credits or equivalent learning hours).
An appropriate examination can be either the relevant ABPI examination (for medical or generic sales representatives) or an examination of at least the same standard as the ABPI examinations and covering similar content and learning material as the corresponding ABPI examination.
16.4 Details of the numbers of representatives who have passed an examination, together with the examination status of others, must be provided to the Prescription Medicines Code of Practice Authority on request.
Clause 16.1 Training
Extensive in house training on the Code is carried out by companies and by the Prescription Medicines Code of Practice Authority.
In addition, the Authority runs seminars on the Code which are open to all companies and personnel from advertising agencies, public relations agencies and the like which act for the pharmaceutical industry. Details of these seminars can be obtained from the Authority.
Clause 16.3 Examinations
The ABPI offers two examinations and further details can be obtained from the ABPI.
Examinations may also be offered by other providers. A company using an examination provider other than the ABPI must be able to demonstrate that its examinations are at least equivalent to those offered by the ABPI. The syllabus studied should be mapped to and meet the requirements in the published ABPI standards. The assessment must be under invigilated examination conditions.
The ABPI Medical Representatives Examination is appropriate for representatives whose duties comprise or include one or both of:
The ABPI Generic Sales Representatives Examination is appropriate for representatives who promote medicines primarily on the basis of price, quality and availability to those who do not prescribe medicines.
The ABPI examinations for medical representatives and generic sales representatives are based on material published by the ABPI.
Persons who have passed the ABPI Medical Representatives Examination or similar whose duties change to those specified for generic sales representatives do not need to take another examination. However, persons who have passed the ABPI Generic Sales Representatives Examination or similar whose duties change to those specified for medical sales representatives must take an appropriate examination within one year of their change of duties and pass it within two years.
Clause 16.3 Introduction of Accredited Examinations
Representatives commencing such employment on or after 1 October 2014 must take an accredited examination. It is recommended that representatives commencing such employment on or after 1 January 2014 but on or before 30 September 2014 also take an accredited examination.
The ABPI will offer accredited examinations by January 2014 and will cease to offer its unaccredited examinations on 31 December 2015.
A candidate who has passed part of an unaccredited ABPI examination will have to complete that examination by 31 December 2015 or transfer to an accredited examination. The limitations on time within which representatives must pass an examination, which are set out in Clause 16.3 and its supplementary information, must be borne in mind.
A candidate who has taken part of an ABPI examination who wishes to transfer to a new provider will have to take the whole of the new provider’s examination. Similarly, a candidate who has taken part of an alternative provider’s examination who wishes to transfer to an ABPI examination will have to take the whole of that examination. This will not apply if it can be demonstrated that the units already passed are equivalent to those of the new provider whether that is an ABPI examination or an alternative provider’s examination.
Clause 16.3 Information from Examination Provider
A company must take steps to ensure that its examination provider would respond to requests for information from the Authority.
Clause 16.3 Time Allowed to Pass an Examination
Prior to passing an appropriate examination, representatives may be engaged in such employment for no more than two years, whether continuous or otherwise and irrespective of whether with one company or with more than one company. A representative cannot, for example, work eighteen months with one company and eighteen months with another and so on, thus avoiding an examination. Maternity or paternity leave does not count towards the specified time periods.
In the event of extenuating circumstances, such as prolonged illness or no or inadequate opportunity to take an appropriate examination, the Director of the Prescription Medicines Code of Practice Authority may agree to the continued employment of a person as a representative past the end of the two year period, subject to the representative passing an appropriate examination within a reasonable time.
Similarly, in the event of failure to take an appropriate examination within the first year, the Director may agree to an extension, subject to the representative taking an examination within a reasonable time.
Service as a representative prior to 1 January 2006 by persons who were exempt from taking the appropriate examination by virtue of Clause 16.4 of the 2003 edition of the Code does not count towards the two year limit on employment as a representative prior to passing the appropriate examination.